

The global Tamsulosin market, valued at approximately USD 2.1 billion in 2024, is witnessing a robust growth trajectory driven by the increasing prevalence of benign prostatic hyperplasia (BPH) among an ageing global population, with over 50% of men over 60 experiencing symptoms. Market dynamics are currently defined by a high penetration of generic formulations, which now account for over 90% of the market share in developed economies, leading to significant price erosion and an Average Wholesale Price (AWP) expected to stabilise between $0.15 and $0.35 per capsule. Furthermore, strategic expansions in the Asia-Pacific region, alongside the development of innovative drug delivery systems such as extended-release tablets and easy-to-swallow capsules, are reshaping urological care and maintaining a projected compound annual growth rate (CAGR) of 4.5% to 7.5% through 2035. We are an established Tamsulosin api supplier with >= 99% purity globally for semi-finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Tamsulosin COA/TDS/SDS region-specific regulatory support, reliable lead times, and worldwide supply chain capabilities.

The global Tamsulosin market, valued at approximately USD 2.1 billion in 2024, is witnessing a robust growth trajectory driven by the increasing prevalence of benign prostatic hyperplasia (BPH) among an ageing global population, with over 50% of men over 60 experiencing symptoms. Market dynamics are currently defined by a high penetration of generic formulations, which now account for over 90% of the market share in developed economies, leading to significant price erosion and an Average Wholesale Price (AWP) expected to stabilise between $0.15 and $0.35 per capsule. Furthermore, strategic expansions in the Asia-Pacific region, alongside the development of innovative drug delivery systems su...

Chemical Properties & Specifications
P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
Acute Tox. 4 (100%)
Skin Irrit. 2 (100%)
A selective alpha-1 adrenergic receptor antagonist primarily used in the treatment of symptomatic benign prostatic hyperplasia (BPH) to improve urine flow by relaxing smooth muscles in the prostate and bladder neck
A prescription medication utilized to alleviate lower urinary tract symptoms such as frequency, urgency, and hesitant urination in male patients
A specific adrenoceptor blocker studied in clinical trials for its efficacy in treating chronic prostatitis and facilitating the passage of distal ureteral stones.
Tamsulosin is a medication belonging to a group called alpha blockers, primarily used to treat the symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH)
This compound is primarily used within the pharmaceutical and healthcare industries for the production of medications aimed at treating urological conditions
Tamsulosin is commonly formulated as oral capsules, tablets, or modified-release tablets, and is often used in combination with other drugs like Dutasteride or Solifenacin
Standard specifications for Tamsulosin include purity testing via HPLC, UV, or LC-MS, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global specialit...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...